N.J. Jury Awards $10.5M In Third Accutane Trial
Drugmaker Hoffmann-La Roche Inc. lost the third of potentially hundreds of trials over its controversial Accutane on Tuesday, when a New Jersey jury awarded $10.5 million to a woman who alleged...To view the full article, register now.
Already a subscriber? Click here to view full article